Good stuff. Have a look at the people behind SBN now (including the top 5 shareholders) rather than past management.
You should be able to get some shares at 0.008 and maybe even 0.007.
Thing are aligning, the only question I have is how howard digby and anton uvarov are going to get some shares (maybe part of an acquisition announcement?) and what's gonna be on issue after a transaction takes place. Given that new shareholders have recently put money in at 1c the risk of a massive dilution is reduced somewhat.
I'm happy to wait out for the markets and biotech sector in general to pick up before they announce anything. I reckon it'll be in the new year tbh to go alongside with the start of their asthma trial.
SBN Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held